EntryPoint Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-32,425
| Closed | -$378K | – | 867 |
|
|
2024
Q4 | $378K | Buy |
+32,425
| New | +$378K | 0.16% | 232 |
|
|
2024
Q3 | – | Sell |
-322
| Closed | -$7.21K | – | 972 |
|
|
2024
Q2 | $7.21K | Sell |
322
-3,800
| -92% | -$85K | 0.01% | 777 |
|
|
2024
Q1 | $113K | Buy |
4,122
+1,563
| +61% | +$43K | 0.1% | 344 |
|
|
2023
Q4 | $78K | Buy |
+2,559
| New | +$78K | 0.07% | 503 |
|